Evidence map›Paper›PMID 22122587›Full record

ArticleNanomedicine (London, England)2011

Photodynamic therapy with fullerenes in vivo: reality or a dream?

Sulbha K Sharma, Long Y Chiang, Michael R Hamblin

Open access · greenAbstract read
In one paragraph

Article in Nanomedicine (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 246 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Putting a "CPharmaceuticals (Basel, Switzerland) · 2023
    Article
  13. Review
  14. Article
  15. Silent Death by Sound: CInternational journal of molecular sciences · 2023
    Article
  16. Human reproduction open · 2023
    Article
  17. Review
  18. Enhanced Uptake and Phototoxicity of CNanomaterials (Basel, Switzerland) · 2022
    Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sulbha K SharmaWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Long Y Chiang
Michael R Hamblin
Massachusetts General Hospital · USUniversity of Massachusetts Lowell · US

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
New Stereoregular Functionalized Fullerenes as Nanomedicines for PDTR01CA137108 · NCI · UNIVERSITY OF MASSACHUSETTS LOWELL · PI CHIANG, LONG Y. · 2009 to 2012
$1.3M
Photodynamic Therapy of Disseminated Peritoneal Tumor Using New PhotosensitizersR44CA103177 · NCI · LYNNTECH, INC. · PI SINGH, WAHEGURU P · 2008 to 2009
$1.2M
NCI NIH HHS R01 CA137108NCI NIH HHS R01CA137108NCI NIH HHS R44 CA103177NCI NIH HHS R44CA103177NIAID NIH HHS R01 AI050875NIAID NIH HHS R01AI050875
6 · The paper itself

Abstract

Photodynamic therapy (PDT) employs the combination of nontoxic photosensitizers and visible light that is absorbed by the chromophore to produce long-lived triplet states that can carry out photochemistry in the presence of oxygen to kill cells. The closed carbon-cage structure found in fullerenes can act as a photosensitizer, especially when functionalized to impart water solubility. Although there are reports of the use of fullerenes to carry out light-mediated destruction of viruses, microorganisms and cancer cells in vitro, the use of fullerenes to mediate PDT of diseases such as cancer and infections in animal models is less well developed. It has recently been shown that fullerene PDT can be used to save the life of mice with wounds infected with pathogenic Gram-negative bacteria. Fullerene PDT has also been used to treat mouse models of various cancers including disseminated metastatic cancer in the peritoneal cavity. In vivo PDT with fullerenes represents a new application in nanomedicine.

Indexed as

PhotochemotherapyAnimalsFullerenesHumansHydroxyl RadicalLightMiceModels, AnimalNanomedicineNeoplasmsPhotochemistryPhotosensitizing AgentsSinglet OxygenSuperoxidesWaterFullerenesHydroxyl RadicalPhotosensitizing AgentsSinglet OxygenSuperoxidesWater

Identifiers

PMID22122587
PMCPMC3433279
OpenAlexW2088146449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.